The Role of CXCL13 in Antibody Responses to HIV-1 Infection and Vaccination
- PMID: 33732259
- PMCID: PMC7959754
- DOI: 10.3389/fimmu.2021.638872
The Role of CXCL13 in Antibody Responses to HIV-1 Infection and Vaccination
Abstract
CXCL13 signals through the G protein-coupled chemokine receptor CXCR5 to drive development of secondary lymphoid tissue as well as B cell and Tfh cell trafficking to germinal centers (GC), which leads to the differentiation of B cells to plasma cells and memory B cells. CXCL13 has been proposed as a general plasma biomarker for GC activities. In HIV-1 infected individuals, plasma CXCL13 levels have been associated with the rate of disease progression to AIDS. Moreover, CXCL13 production has been reported to be increased in HIV-1-infected lymph nodes, which may drive increased downregulation of CXCR5. In this review, we address the role of CXCL13 in HIV-1 infected individuals with regard to GC formation, generation of broadly neutralizing antibodies after infection and vaccination, and AIDS-related B cell lymphoma.
Keywords: CXCL13; CXCR5; HIV-1; broadly neutralizing antibodies; vaccine.
Copyright © 2021 Bekele Feyissa, Chiodi, Sui and Berzofsky.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures

Similar articles
-
Plasma IL-5 but Not CXCL13 Correlates With Neutralization Breadth in HIV-Infected Children.Front Immunol. 2019 Jul 2;10:1497. doi: 10.3389/fimmu.2019.01497. eCollection 2019. Front Immunol. 2019. PMID: 31333650 Free PMC article.
-
CXCL13 is a plasma biomarker of germinal center activity.Proc Natl Acad Sci U S A. 2016 Mar 8;113(10):2702-7. doi: 10.1073/pnas.1520112113. Epub 2016 Feb 23. Proc Natl Acad Sci U S A. 2016. PMID: 26908875 Free PMC article.
-
Tfh cells and HIV bnAbs, an immunodominance model of the HIV neutralizing antibody generation problem.Immunol Rev. 2017 Jan;275(1):49-61. doi: 10.1111/imr.12512. Immunol Rev. 2017. PMID: 28133798 Review.
-
Distinct Immunoglobulin Fc Glycosylation Patterns Are Associated with Disease Nonprogression and Broadly Neutralizing Antibody Responses in Children with HIV Infection.mSphere. 2020 Dec 23;5(6):e00880-20. doi: 10.1128/mSphere.00880-20. mSphere. 2020. PMID: 33361123 Free PMC article.
-
The role of follicular helper CD4 T cells in the development of HIV-1 specific broadly neutralizing antibody responses.Retrovirology. 2018 Aug 6;15(1):54. doi: 10.1186/s12977-018-0437-y. Retrovirology. 2018. PMID: 30081906 Free PMC article. Review.
Cited by
-
CXCL13 promotes broad immune responses induced by circular RNA vaccines.Proc Natl Acad Sci U S A. 2024 Oct 29;121(44):e2406434121. doi: 10.1073/pnas.2406434121. Epub 2024 Oct 22. Proc Natl Acad Sci U S A. 2024. PMID: 39436660 Free PMC article.
-
An mRNA-based T-cell-inducing antigen strengthens COVID-19 vaccine against SARS-CoV-2 variants.Nat Commun. 2023 May 23;14(1):2962. doi: 10.1038/s41467-023-38751-8. Nat Commun. 2023. PMID: 37221158 Free PMC article.
-
Role of chemokine systems in cancer and inflammatory diseases.MedComm (2020). 2022 Jun 8;3(2):e147. doi: 10.1002/mco2.147. eCollection 2022 Jun. MedComm (2020). 2022. PMID: 35702353 Free PMC article. Review.
-
The CXCL13/CXCR5 Immune Axis in Health and Disease-Implications for Intrathecal B Cell Activities in Neuroinflammation.Cells. 2022 Aug 25;11(17):2649. doi: 10.3390/cells11172649. Cells. 2022. PMID: 36078057 Free PMC article. Review.
-
Rapid transient and longer-lasting innate cytokine changes associated with adaptive immunity after repeated SARS-CoV-2 BNT162b2 mRNA vaccinations.Front Immunol. 2023 Nov 27;14:1292568. doi: 10.3389/fimmu.2023.1292568. eCollection 2023. Front Immunol. 2023. PMID: 38090597 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous